Pallesen, Ståle
Universitetet i Bergen,
Norway
2025 Rank: 26764
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Substance Abuse
Rank in SubField 1: 1245 out of 360881 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26764 | 28932 |
| Total Cites | 3007 | 3192 |
| H-index | 21 | 22 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 130 | 138 |
| Number of Single+First+Last Authored Papers | 225 | 225 |
| Total Cites to Single+First+Last Authored Papers | 1568 | 1629 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2324 | 2392 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.33 |
| Self-Citation Percentage |
5.80%
|
|
Pallesen, Ståle
Universitetet i Bergen,
Norway
2024 Rank: 24079
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Substance Abuse
Rank in SubField 1: 1168 out of 341636 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24079 | 25889 |
| Total Cites | 2854 | 3085 |
| H-index | 22 | 22 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 130 | 151 |
| Number of Single+First+Last Authored Papers | 222 | 222 |
| Total Cites to Single+First+Last Authored Papers | 1497 | 1618 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2200 | 2291 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.35 |
| Self-Citation Percentage |
7.49%
|
|
Pallesen, Ståle
Universitetet i Bergen,
Norway
2023 Rank: 24783
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Substance Abuse
Rank in SubField 1: 1315 out of 323273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24783 | 24006 |
| Total Cites | 2868 | 3184 |
| H-index | 23 | 24 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 125 | 145 |
| Number of Single+First+Last Authored Papers | 206 | 206 |
| Total Cites to Single+First+Last Authored Papers | 1442 | 1590 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2173 | 2291 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.39 |
| Self-Citation Percentage |
9.92%
|
|
Pallesen, Ståle
Universitetet i Bergen,
Norway
2022 Rank: 28042
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Substance Abuse
Rank in SubField 1: 1623 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28042 | 25381 |
| Total Cites | 2446 | 2806 |
| H-index | 23 | 25 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 109 | 136 |
| Number of Single+First+Last Authored Papers | 194 | 194 |
| Total Cites to Single+First+Last Authored Papers | 1246 | 1424 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1854 | 1978 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.42 |
| Self-Citation Percentage |
12.83%
|
|
Pallesen, Ståle
Universitetet i Bergen,
Norway
2021 Rank: 31341
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Substance Abuse
Rank in SubField 1: 1769 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31341 | 29241 |
| Total Cites | 3471 | 3947 |
| H-index | 26 | 29 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 164 | 205 |
| Number of Single+First+Last Authored Papers | 182 | 182 |
| Total Cites to Single+First+Last Authored Papers | 1780 | 2029 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2642 | 2825 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.40 |
| Self-Citation Percentage |
12.06%
|
|
Pallesen, Ståle
Universitetet i Bergen,
Norway
2020 Rank: 32978
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Substance Abuse
Rank in SubField 1: 1892 out of 227881 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32978 | 30590 |
| Total Cites | 2353 | 2685 |
| H-index | 20 | 22 |
| Hm-index | 10 | 11 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 31 | 31 |
| Total Cites to Single+First Authored Papers | 138 | 163 |
| Number of Single+First+Last Authored Papers | 170 | 170 |
| Total Cites to Single+First+Last Authored Papers | 1280 | 1465 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1761 | 1870 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.44 |
| Self-Citation Percentage |
12.36%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.